Document:

Tender and Support Agreement

 Exhibit 10.1 
 Execution Version 
 TENDER AND SUPPORT AGREEMENT 

This TENDER AND SUPPORT AGREEMENT, dated as of January 22, 2013 (this “Agreement”), is made among Allergan, Inc., a
Delaware corporation (“Parent”), Groundhog Acquisition, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“Purchaser”), and each of the individuals or entities listed on a signature page hereto
(each, a “Stockholder”). Capitalized terms used but not defined herein have the meanings set forth in the Agreement and Plan of Merger, dated as of the date of this Agreement (the “Merger Agreement”), among Parent,
Purchaser and MAP Pharmaceuticals, Inc., a Delaware corporation (the “Company”). 
 WHEREAS, each
Stockholder owns of record, or beneficially (as defined in Rule 13d-3 under the Securities Exchange Act of 1934, as amended), shares of common stock of the Company, par value $0.01 per share (“Shares”); 

WHEREAS, concurrently with the execution and delivery of this Agreement, Parent, Purchaser and the Company are entering into the Merger
Agreement, a copy of which has been made available to each Stockholder, which provides for, among other things, the making of a tender offer (such offer, as it may be amended from time to time as permitted by the Merger Agreement, the
“Offer”) by Purchaser for all of the outstanding Shares, and the subsequent merger of Purchaser with and into the Company (the “Merger”), each upon the terms and subject to the conditions set forth therein;

 WHEREAS, as an inducement and condition to Parent’s and Purchaser’s willingness to enter into the Merger Agreement,
Parent has required that each Stockholder enter into this Agreement; 
 WHEREAS, the Company and certain stockholders of the
Company, including certain of the Stockholders, are parties to that certain Third Amended and Restated Registration Rights Agreement, dated as of March 21, 2007 (the “Registration Rights Agreement”); and 

WHEREAS, each Stockholder who is a party to the Registration Rights Agreement has agreed that such Stockholder will not, to the extent
set forth herein, exercise any of its rights under the Registration Rights Agreement. 
 NOW, THEREFORE, in consideration of the
foregoing and of the mutual covenants, representations, warranties and agreements set forth herein, the parties hereby agree as follows: 
 SECTION 1. Covenant To Tender 
 (a) Unless this Agreement shall have
been terminated in accordance with its terms, each Stockholder shall validly tender, or cause to be tendered, in the Offer (i) any and all Shares currently owned (of record or beneficially) by such Stockholder and (ii) any additional
Shares that such Stockholder acquires in any manner after the date of this Agreement (collectively, the “Subject Shares”), pursuant to and in accordance with the terms of the Offer;

 
provided, however, that (x) a Stockholder shall not be required, for purposes of this Agreement, to exercise any unexercised Company Stock Option held by such Stockholder and (y) a
Stockholder shall not have any obligation under this Section 1(a) to tender any Subject Shares into the Offer to extent such shares constitute Company Restricted Stock Awards or Company RSUs or if that tender could cause such Stockholder
to incur liability under Section 16(b) of the Exchange Act. 
 (b) Each Stockholder agrees that once its or his Subject
Shares are tendered, such Stockholder will not withdraw or cause to be withdrawn any of such Subject Shares from the Offer; unless and until (A) the Offer shall have been terminated by the Purchaser in accordance with the terms of the Merger
Agreement or (B) this Agreement shall have been terminated in accordance with its terms. 
 (c) If a Stockholder owns
Subject Shares beneficially, but not of record, then such Stockholder shall promptly, but in any event no later than ten (10) Business Days before the originally scheduled Acceptance Date, cause the nominee that holds such Subject Shares to
tender all such beneficially owned Subject Shares. 
 (d) If a Stockholder owns Subject Shares of record, then such Stockholder
shall promptly, but in any event no later than ten (10) Business Days before the originally scheduled Acceptance Date, tender all such Subject Shares owned of record. 
 (e) In furtherance of the foregoing, at the time of tendering the Subject Shares, each Stockholder shall (i) deliver to the depositary designated in the Offer (the “Depositary”)
(A) a letter of transmittal with respect to its or his Subject Shares complying with the terms of the Offer, (B) a certificate or certificates representing such Subject Shares or an “agent’s message” (or such other evidence,
if any, of transfer as the Depositary may reasonably request) in the case of a book-entry transfer of any Subject Shares and (C) all other documents or instruments, to the extent applicable, in the form required to be delivered by the other
stockholders of the Company pursuant to the terms of the Offer, and/or (ii) instruct its or his broker or such other Person that is the holder of record of any Subject Shares to tender such Subject Shares pursuant to and in accordance with the
terms of the Offer. 
 SECTION 2. Documentation and Information. Each Stockholder: (i) consents to the
publication and disclosure by Parent of such Stockholder’s identity and holdings of Subject Shares in all documents and schedules filed with the SEC and the existence and terms of this Agreement that Parent reasonably determines, in its sole
discretion, should be publicly disclosed under applicable Law in connection with the Offer, the Merger or any transactions contemplated by the Merger Agreement; and (ii) shall promptly give to Parent any information that Parent may reasonably
require for the preparation of any applicable disclosure documents. Each Stockholder shall promptly notify Parent of any inaccuracies or omissions with respect to any information supplied by such Stockholder to Parent. 

SECTION 3. Voting Agreement. Each Stockholder shall, at any meeting (whether annual or special and whether or not an
adjourned or postponed meeting) of the holders of Shares (a “Company Stockholders Meeting”): 

  
 2 

 (a) be present, in person or represented by proxy, or otherwise cause such
Stockholder’s Subject Shares to be counted for purposes of determining the presence of a quorum at such meeting; and 
 (b)
vote (or cause to be voted) with respect to all such Stockholder’s Subject Shares (to the extent that any of such Stockholder’s Subject Shares have not been purchased in the Offer prior to the record date with respect to such vote):

 (i) in favor of the adoption of the Merger Agreement; 

(ii) in favor of any proposal to adjourn the Company Stockholders Meeting to a later date if there are not sufficient
votes for adoption of the Merger Agreement on the date on which the Company Stockholders Meeting is held; and 

(iii) against (A) any proposal that could reasonably be expected to, directly or indirectly, impede, interfere with,
delay, postpone, discourage or adversely affect the consummation of the Offer or Merger, (B) any Acquisition Proposal and any action in furtherance of any Acquisition Proposal, and (C) any action, proposal, transaction or agreement that
would reasonably be expected to result in a breach of any covenant, representation or warranty or any other obligation or agreement of such Stockholder under this Agreement or, to such Stockholder’s knowledge, of the Company under the Merger
Agreement. 
 SECTION 4. Irrevocable Proxy. 
 (a) Each Stockholder hereby revokes (or agrees to cause to be revoked) any proxies that it has heretofore granted with respect to the Subject Shares. 

(b) Each Stockholder hereby irrevocably appoints Parent as attorney-in-fact and proxy, with full power of substitution and resubstitution,
for and on behalf of such Stockholder, for and in the name, place and stead of such Stockholder, to: 
 (i)
attend any and all Company Stockholder Meetings and represent the Stockholder at such Company Stockholder Meetings; 
 (ii) vote, or issue instructions to the record holder to vote, such Stockholder’s Subject Shares in accordance with the provisions of Section 3 at any and all Company Stockholder
Meetings; and 
 (iii) grant or withhold, or issue instructions to the record holder to grant or withhold, in
accordance with the provisions of Section 3, all written consents with respect to the Subject Shares at any and all Company Stockholder Meetings. 
 (c) Each Stockholder hereby affirms that (i) the proxy set forth in this Section 4 (the “Proxy”) is granted in consideration of, and as an inducement to, Parent and
Purchaser entering into the Merger Agreement, and (ii) that the Proxy is given to secure the obligations of such Stockholder under Section 3 hereof. Each Stockholder hereby further affirms that the Proxy is therefore coupled with an
interest and shall be irrevocable during the Agreement Period (as defined below). The Proxy shall automatically terminate upon the termination of this Agreement. 

  
 3 

 (d) Each Stockholder authorizes such attorney and proxy to substitute any other Person to
act hereunder, to revoke any substitution and to file the Proxy and any substitution or revocation with the Secretary of the Company. 
 (e) Parent agrees not to exercise the Proxy for any purpose other than the purposes described in this Agreement. 
 SECTION 5. Representations and Warranties of Each Stockholder. Each Stockholder, for itself and not as to any other Stockholder, represents and warrants to Parent and Purchaser, as of the date
hereof, as follows: 
 (a) Organization. If such Stockholder is not an individual, it is duly organized and validly
existing and in good standing under the laws of the jurisdiction of its organization. 
 (b) Authorization. 

(i) If such Stockholder is an individual, such Stockholder has full legal capacity, right and authority to execute and
deliver this Agreement and to perform such Stockholder’s obligations hereunder. 
 (ii) If such Stockholder
is not an individual, it has full corporate, limited liability company, partnership or trust power and authority to execute and deliver this Agreement and to perform its obligations hereunder, and the execution, delivery and performance by such
Stockholder of this Agreement and the consummation by such Stockholder of the transactions contemplated hereby have been duly authorized by all necessary action on the part of such Stockholder. 

(c) Due Execution and Delivery. This Agreement has been duly executed and delivered to Parent and Purchaser by such Stockholder and
constitutes a valid and legally binding obligation of such Stockholder in accordance with its terms, subject to the effects of bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and other similar Laws relating to or affecting
creditors’ rights generally and general equitable principles (whether considered in a proceeding in equity or at law). If such Stockholder is married, and any of the Subject Shares of such Stockholder constitute community property or otherwise
need spousal or other approval for this Agreement to be legal, valid and binding, this Agreement has been duly and validly executed and delivered by such Stockholder’s spouse and, assuming due authorization, execution and delivery by Parent,
constitutes a valid and legally binding obligation of such Stockholder’s spouse in accordance with its terms, subject to the effects of bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and other similar Laws relating to
or affecting creditors’ rights generally and general equitable principles (whether considered in a proceeding in equity or at law). 

  
 4 

 (d) No Violation. 

(i) The execution and delivery of this Agreement by such Stockholder does not, and the performance by such Stockholder of
such Stockholder’s obligations hereunder will not: (A) to the knowledge of such Stockholder, materially conflict with or violate any Law applicable to such Stockholder or by which such Stockholder or any of such Stockholder’s
properties is bound; or (B) result in or constitute (with or without notice or lapse of time) any material breach of or default under, or give to any third party (with or without notice or lapse of time) any right of termination, amendment,
acceleration or cancellation of, or result (with or without notice or lapse of time) in the creation of any encumbrance or restriction on any of the Subject Shares pursuant to, any contract to which such Stockholder is a party or by which such
Stockholder or any of its or his Affiliates or properties is bound, in each case, whether individually or in the aggregate, that would reasonably be expected to prevent or delay or impair the consummation by such Stockholder of the transactions
contemplated by this Agreement or otherwise negatively impact Stockholder’s ability to perform its obligations hereunder. 
 (ii) The execution and delivery of this Agreement and the Proxy by such Stockholder do not, and the performance of this Agreement and the Proxy by such Stockholder will not, require any consent or
approval of any Person. 
 (iii) No consent, approval, order, authorization or permit of, or registration,
declaration or filing with or notification to, any Governmental Entity or any other Person is required by or with respect to such Stockholder in connection with the execution and delivery of this Agreement by such Stockholder or the performance by
such Stockholder of such Stockholder’s obligations hereunder, except for the filing with the SEC of any Schedules 13D or 13G or amendments to Schedules 13D or 13G and filings under Section 16 of the Exchange Act as may be required in
connection with this Agreement and the transactions contemplated hereby. 
 (e) Ownership of Subject Shares. 

(i) Such Stockholder is, and (except with respect to any Subject Shares Transferred (as defined below) in accordance with
Section 7(b) hereof or accepted for payment pursuant to the Offer) at all times during the Agreement Period will be, the holder of record or beneficially of the Stockholder’s Subject Shares, free and clear of any encumbrances or
restrictions, except (i) pursuant to any applicable restrictions on transfer under the Securities Act and (ii) subject to any risk of forfeiture with respect to any shares of Common Stock granted to such Stockholder under an employee
benefit plan of the Company. 

  
 5 

 (ii) Except as provided in this Agreement or, if such Stockholder is a
partnership, pursuant to such Stockholder’s partnership agreement (which partnership agreement does not prevent such Stockholder from performing its obligations hereunder), there are no agreements or arrangements of any kind, contingent or
otherwise, obligating Stockholder to Transfer or cause to be Transferred, any of such Stockholder’s Subject Shares. 
 (iii) Except pursuant to this Agreement, no Person has any right or obligation to purchase or otherwise acquire any of such Stockholder’s Subject Shares. 

(f) Number of Shares. Except to the extent of any Subject Shares acquired after the date hereof (which shall become Subject Shares
upon that acquisition), the Subject Shares set forth on Schedule A opposite the name of such Stockholder are the only Shares owned beneficially or of record by such Stockholder on the date of this Agreement. Other than as set forth on
Schedule A, such Stockholder does not own any Shares or any options to purchase or otherwise acquire any securities of the Company, and has no interest in or voting rights with respect to any securities of the Company. 

(g) No Other Proxies. None of such Stockholder’s Subject Shares are subject to any voting agreement or proxy on the date of
this Agreement, except pursuant to this Agreement. 
 (h) Absence of Litigation. With respect to such Stockholder, as of
the date hereof, there is no action, suit, investigation or proceeding pending against, or, to the knowledge of such Stockholder, threatened against or otherwise affecting, such Stockholder or any of such Stockholder’s properties or assets
(including such Stockholder’s Subject Shares) that would reasonably be expected to impair the ability of such Stockholder to perform its, her or his obligations hereunder or to consummate the transactions contemplated hereby on a timely basis.

 (i) Opportunity to Review. Such Stockholder has had the opportunity to review the Merger Agreement and this Agreement
with counsel of its or his own choosing. Such Stockholder understands and acknowledges that Parent and Purchaser are entering into the Merger Agreement in reliance upon such Stockholder’s execution, delivery and performance of this Agreement.

 (j) Finders’ Fees. No investment banker, broker, finder or other intermediary is entitled to a fee or commission
from Parent, Purchaser or the Company in respect of this Agreement based upon any arrangement or agreement made by or on behalf of such Stockholder in its or his capacity as such. 

SECTION 6. Representations and Warranties of Parent and Purchaser. Each of Parent and Purchaser hereby, severally and not
jointly, represent and warrant to each Stockholder, as of the date hereof, that (a) such party has full power and authority to execute and deliver this Agreement and to perform its obligations hereunder, (b) the execution, delivery and
performance by such party of this Agreement and the consummation by such party of the transactions contemplated hereby have been duly authorized by all necessary action on the part of such party and (c) this Agreement constitutes a valid and
legally binding obligation of such party in accordance with its terms, subject to the effects of bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and other similar Laws relating to or affecting creditors’ rights
generally and general equitable principles (whether considered in a proceeding in equity or at law). 

  
 6 

 SECTION 7. No Proxies for, Transfers of, or Liens on Subject Shares. 

(a) Except pursuant to the terms of this Agreement, during the Agreement Period, no Stockholder shall, without the prior written consent
of Parent, directly or indirectly: 
 (i) grant any proxies, powers of attorney, rights of first offer or
refusal, or enter into any voting trust or voting agreement or arrangement with respect to any Subject Shares, 

(ii) sell (including short sell), assign, transfer, tender, pledge, encumber, grant a participation interest in,
hypothecate or otherwise dispose of (including by gift) (each, a “Transfer”) any Subject Shares, 
 (iii) otherwise permit any Liens to be created on any Subject Shares, 
 (iv) enter into any contract, agreement, option, instrument or other arrangement or understanding with respect to the direct or indirect Transfer of any Subject Shares, or 

(v) consent to any of the foregoing. 
 (b) Notwithstanding the foregoing, each Stockholder shall have the right to Transfer all or any portion of its or his Subject Shares to a Permitted Transferee of such Stockholder, if and only if such
Permitted Transferee shall have agreed in writing, in a manner reasonably acceptable in form and substance to Parent, (i) to accept such Subject Shares subject to the terms and conditions of this Agreement and (ii) to be bound by this
Agreement and to agree and acknowledge that such Person shall constitute a Stockholder for all purposes of this Agreement. “Permitted Transferee” means, with respect to any Stockholder, (A) any other Stockholder, (B) a
spouse, lineal descendant or antecedent, brother or sister, adopted child or grandchild or the spouse of any child, adopted child, grandchild or adopted grandchild of such Stockholder, (C) any trust, the trustees of which include only the
Persons named in clauses (A) or (B) and the beneficiaries of which include only the Persons named in clauses (A) or (B), (D) any corporation, limited liability company or partnership, the stockholders, members or general or
limited partners of which include only the Persons named in clauses (A) or (B), (E) if such Stockholder is a partnership, its limited partners or (F) if such Stockholder is a trust, the beneficiary or beneficiaries authorized or
entitled to receive distributions from such trust. Notwithstanding anything to the contrary contained herein, each Stockholder shall have the right to make Transfers of Subject Shares by will, operation of law, Transfers for estate planning purposes
or Transfers for charitable purposes or as charitable gifts or donations, in which case the transferee of such Subject Shares shall constitute a Permitted Transferee, subject to the requirements set forth in the first sentence of this clause (b).

 (c) Each Stockholder hereby authorizes Parent and Purchaser to direct the Company to affix to any certificate representing
Subject Shares a legend reflecting the transfer restrictions on the Subject Shares pursuant to this Agreement and to impose stop orders to prevent the Transfer of any Subject Shares on the books of the Company in violation of this Agreement.

  
 7 

 SECTION 8. Notices of Certain Events. Each Stockholder shall notify Parent of
any development occurring after the date hereof that causes, or that would reasonably be expected to cause, any breach of any of the representations and warranties of such Stockholder set forth in Section 5. 

SECTION 9. Further Assurances. Parent and each Stockholder will each execute and deliver, or cause to be executed and
delivered, all further documents and instruments, and use their respective reasonable best efforts to take, or cause to be taken, all actions and to do, or cause to be done, all things, necessary to perform their respective obligations under this
Agreement. 
 SECTION 10. Certain Adjustments. In the event of a stock split, stock dividend or distribution, or any
change in the Shares by reason of a stock split, reverse stock split, recapitalization, combination, reclassification, readjustment, exchange of shares or the like, the term “Subject Shares” shall be deemed to refer to and include such
shares, as well as all such stock dividends and distributions and any securities into which or for which any or all of such shares may be changed or exchanged or which are received in the transaction. 

SECTION 11. Waiver of Appraisal and Dissenter’s Rights. Each Stockholder waives and agrees not to exercise any rights of
appraisal, rights to dissent or similar rights with respect to the Merger or other transactions contemplated by the Merger Agreement that such Stockholder may have with respect to such Stockholder’s Subject Shares pursuant to Section 262
of the Delaware General Corporation Law or other applicable Law. 
 SECTION 12. Registration Rights
Agreement. 
 (a) Each Stockholder that is a party to the Registration Rights Agreement hereby agrees that: (i) during
the Agreement Period such Stockholder will not exercise any of its rights under the Registration Rights Agreement without the express prior written consent of Parent and (ii) as of the Effective Time, without any further or additional action by
any of the parties, the Company, Parent, Purchaser and such Stockholder shall have no further rights, obligations or duties in respect of one another under the Registration Rights Agreement or in respect thereof. 

(b) Notwithstanding anything to the contrary set forth herein, upon the termination of the Merger Agreement in accordance with its terms,
the Registration Rights Agreement shall remain in full force and effect. 
 SECTION 13. Miscellaneous. 

(a) Notices. All notices and other communications hereunder shall be in writing and shall be deemed duly given (i) on the date
of delivery if delivered personally, or if by facsimile, upon written confirmation of receipt by facsimile, (ii) on the first Business Day following the date of dispatch if delivered utilizing a next-day service by a recognized next-day courier
or (iii) on the earlier of confirmed receipt or the fifth Business Day following the date of 

  
 8 

 
mailing if delivered by registered or certified mail, return receipt requested, postage prepaid. All notices hereunder shall be delivered to the addresses set forth below, or pursuant to such
other instructions as may be designated in writing by the party to receive such notice: 
 If to Parent or Purchaser, to:

 Allergan, Inc. 
 2525 Dupont Drive 
 Irvine, California 92612 

Attention: General Counsel 
 Facsimile No.: (714) 246-4774 
 with a copy to: 

Gibson, Dunn & Crutcher LLP 
 3161 Michelson Drive, Suite 1200 
 Irvine, California 92612 

Attention: Terrence Allen, Esq. 
 Facsimile: (949) 475-4724 
 If to a Stockholder, to its or his address set
forth on a signature page hereto, with a copy to: 
 Latham & Watkins LLP 

140 Scott Drive 

Menlo Park, California 94025 
 Attention: Patrick A. Pohlen 
 Facsimile No.: (650) 463-2600 

(b) Amendment and Waivers. 
 (i) Any provision of this Agreement may be amended or waived during the Agreement Period if, but only if, such amendment or waiver is in writing and is signed, in the case of an amendment, by each party
to this Agreement or, in the case of a waiver, by each party against whom the waiver is to be effective. 
 (ii)
No failure or delay by any party in exercising any right, power or privilege hereunder shall operate as a waiver thereof nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any other
right, power or privilege. The rights and remedies herein provided shall be cumulative and not exclusive of any rights or remedies provided by Law. 
 (c) Binding Effect; Benefit; Assignment. 
 (i) The
provisions of this Agreement shall be binding upon and shall inure to the benefit of the parties hereto and their respective successors and assigns. No provision of this Agreement is intended to confer any rights, benefits, remedies, obligations or
liabilities hereunder upon any Person other than the parties hereto and their respective successors and assigns. 

  
 9 

 (ii) Neither any Stockholder, on the one hand, nor Parent or Purchaser, on
the other hand, may assign this Agreement or any of its or his rights, interests or obligations hereunder (whether by operation of Law or otherwise) without the prior written approval of Parent or such Stockholder, as applicable, except that each of
Parent and Purchaser may assign their respective rights and obligations under this Agreement, in whole or from time to time in part, to one or more of their respective Affiliates at any time; provided that such assignment shall not relieve
such Person of its or his obligations under this Agreement. 
 (d) Termination. This Agreement shall automatically
terminate and become void and of no further force or effect on the earlier of (i) the Effective Time, (ii) the termination of this Agreement by written notice from Parent to the Stockholders, (iii) the occurrence of a Triggering
Event, (iv) the termination of the Merger Agreement in accordance with its terms, and (v) the date of any amendment to the Merger Agreement that reduces the amount, or changes the form, of consideration payable to the stockholders of the
Company pursuant to the terms of the Merger Agreement (the period from the date hereof through such time being referred to as the “Agreement Period”); provided that (A) Sections 13(a), 13(b),
13(e), 13(h) and 13(n) shall survive such termination and (B) no such termination shall relieve or release any Stockholder, Parent or Purchaser from any obligations or liabilities arising out of its, her or his breach of
this Agreement prior to its termination. 
 (e) Governing Law; Consent to Jurisdiction; Waiver of Jury Trial. 

(i) This Agreement shall be governed by, and construed in accordance with, the Laws of the State of Delaware, without
regard to laws that may be applicable under conflicts of laws principles (whether of the State of Delaware or any other jurisdiction) that would cause the application of the Laws of any jurisdiction other than the State of Delaware. 

(ii) Each of the parties hereto hereby irrevocably and unconditionally submits, for itself or himself and its or his
property, to the exclusive jurisdiction of the Court of Chancery of the State of Delaware (or another Delaware state court if the Court of Chancery lacks jurisdiction), or Federal court of the United States of America, sitting in Delaware, and any
appellate court from any thereof, in any action or proceeding arising out of or relating to this Agreement or the agreements delivered in connection herewith or the transactions contemplated hereby or thereby or for recognition or enforcement of any
judgment relating thereto, and each of the parties hereby irrevocably and unconditionally (a) agrees not to commence any such action or proceeding except in such courts, (b) agrees that any claim in respect of any such action or proceeding
may be heard and determined in such Delaware State court or, to the extent permitted by law, in such Federal court, (c) waives, to the fullest extent it may legally and effectively do so, any objection which it may now or hereafter have to the
laying of venue of any such action or proceeding in any such Delaware State or Federal court and (d)

  
 10 

 
waives, to the fullest extent permitted by Law, the defense of an inconvenient forum to the maintenance of such action or proceeding in any such Delaware State or Federal court. Each of the
parties hereto agrees that a final judgment in any such action or proceeding shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by Law. Each party to this Agreement irrevocably
consents to service of process in the manner provided for notices in Section 13(a). Nothing in this Agreement will affect the right of any party to this Agreement to serve process in any other manner permitted by Law. Notwithstanding for
foregoing, in furtherance of the agreements of the parties in this Section 13(e), each Stockholder that has not as of the date hereof already duly appointed an agent for service of process in Delaware does hereby appoint RL&F Service
Corp., One Rodney Square, Tenth Floor, Wilmington, New Castle County, Delaware 19801, as such agent. 
 (iii)
EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE IT OR HE HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT IT OR HE MAY HAVE TO A
TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT AND ANY OF THE AGREEMENTS DELIVERED IN CONNECTION HEREWITH OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY. EACH PARTY CERTIFIES AND
ACKNOWLEDGES THAT (A) NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE EITHER OF SUCH WAIVERS, (B) IT OR HE
UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF SUCH WAIVERS, (C) IT OR HE MAKES SUCH WAIVERS VOLUNTARILY AND (D) IT OR HE HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN
THIS SECTION 13(e)(iii). 
 (f) Severability. If any term, provision, covenant or restriction of this Agreement is held by
a court of competent jurisdiction to be invalid, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions of this Agreement shall remain in full force and effect and shall in no way be affected so long as the
economic or legal substance of the transactions contemplated hereby is not affected in any manner materially adverse to any party. Upon such a determination, the parties shall negotiate in good faith to modify this Agreement so as to effect the
original intent of the parties as closely as possible in an acceptable manner in order that the transactions contemplated hereby be consummated as originally contemplated to the fullest extent possible. 

(g) Specific Performance. The parties hereto agree that irreparable damage would occur if any provision of this Agreement were not
performed in accordance with the terms hereof and that the parties shall be entitled to an injunction or injunctions to prevent breaches of this Agreement or to enforce specifically the performance of the terms and provisions hereof, in addition to
any other remedy to which they are entitled at law or in equity. 

  
 11 

 (h) Expenses. All costs and expenses incurred in connection with this Agreement shall
be paid by or on behalf of the party incurring such cost or expense, whether or not the transactions contemplated by this Agreement are consummated. 
 (i) Counterparts; Effectiveness. This Agreement may be signed in any number of counterparts, each of which shall be an original, with the same effect as if the signatures thereto and hereto were
upon the same instrument. 
 (j) Entire Agreement. This Agreement constitutes the entire agreement between the parties
with respect to the subject matter hereof and supersedes all prior agreements and understandings, both oral and written, between the parties with respect to the subject matter hereof. 

(k) Headings. The Section headings contained in this Agreement are inserted for convenience only and shall not affect in any way
the meaning or interpretation of this Agreement. 
 (l) Interpretation. When a reference is made in this Agreement to
Sections or Schedules, such reference shall be to a Section of or Schedule to this Agreement unless otherwise indicated. Whenever the words “include,” “includes” or “including” are used in this Agreement, they shall be
deemed to be followed by the words “without limitation.” Whenever the words “his” and “him” are used in this Agreement, they shall be deemed to also include “her”. In this Agreement, the Stockholder of any
Shares held in trust shall be deemed to be the relevant trust and/or the trustees thereof acting in their capacities as such trustees, in each case as the context may require to be most protective of Parent, including for purposes of such
trustees’ representations and warranties as to the proper organization of the trust, their power and authority as trustees and the non-contravention of the trust’s governing instruments. 

(m) No Presumption. This Agreement shall be construed without regard to any presumption or rule requiring construction or
interpretation against the party drafting or causing any instrument to be drafted. 
 (n) Obligations. The obligations of
each Stockholder under this Agreement are several and not joint, and no Stockholder shall have any liability or obligation under this Agreement for any breach hereunder by any other Stockholder. 

(o) Stockholder Capacity. Each Stockholder is signing and entering this Agreement solely in his capacity as the record or
beneficial owner of Subject Shares, and nothing herein shall limit or affect in any way any actions that may be hereafter taken by him in his capacity as an employee, officer or director of the Company or any Subsidiary of the Company or in his or
her capacity as a trustee or fiduciary of any employee benefit plan or trust or prevent or be construed to create any obligation on the part of any director or officer of the Company or any trustee or fiduciary of any employee benefit plan or trust
from taking any action in his or her capacity as such director, officer, trustee or fiduciary. 

  
 12 

 (p) Non-Survival of Representations and Warranties. None of the representations and
warranties in this Agreement or in any instrument delivered pursuant to this Agreement shall survive the Effective Time. 
 (q)
No Agreement Until Executed. Irrespective of negotiations among the parties or the exchanging of drafts of this Agreement, this Agreement shall not constitute or be deemed to evidence a contract, agreement, arrangement or understanding
between the parties hereto unless and until (a) the Board of Directors of the Company has approved, for purposes of any applicable anti-takeover laws and regulations, and any applicable provision of the Company’s organizational documents,
the possible acquisition of the Subject Shares by Parent and Purchaser pursuant to the Merger Agreement, (b) the Merger Agreement is executed by all parties thereto and (c) this Agreement is executed by all parties hereto. 

(r) 10b5-1 Plans. Notwithstanding anything to the contrary set forth in this Agreement, each of the Stockholders identified on
Schedule A as being a party, as of the date hereof, to a written plan for trading the Shares in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (each, a “10b5-1 Plan”), may sell pursuant to such
Stockholder’s 10b5-1 Plan up to that number of Shares indicated on Schedule A as permitted to be sold under such 10b5-1 Plan, which Shares shall be those issued upon the exercise of stock options outstanding as of the date hereof or Shares
outstanding as of the date hereof, as the case may be, solely as specified in Schedule A. If Shares are sold pursuant to a Rule 10b5-1 Plan, then the applicable Stockholder on behalf of whom such Shares are sold, shall provide prompt (and in
any event within three Business Days) written notice to Parent of such sale, including the amount of Shares sold. Each such Stockholder has made available to Parent an accurate and complete copy of such Stockholder’s 10b5-1 Plan as in effect on
the date hereof, and each such 10b5-1 Plan shall not be amended during the Agreement Period. 
 [The next page is the signature
page] 

  
 13 

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written
above. 
  

			
	Allergan, Inc.
		
	By:	 	 
	Name:	 	
	Title:	 	
	
	Groundhog Acquisition, Inc.
		
	By:	 	 
	Name:	 	
	Title:	 	

 [Stockholder signatures begin on the next page] 

Signature Page to Tender and Support Agreement 

 
			
	STOCKHOLDER
	
	Brookside Capital Partners Fund, L.P.
	
	 
	Name:	 	 
	Title:	 	 
	Address:	 	200 Clarendon Street
		 	Boston, MA 02116
	Facsimile:	 	 

 Signature Page to Tender and Support Agreement 

 
			
	STOCKHOLDER
	
	/s/ Timothy S. Nelson
	Name: 	 	Timothy S. Nelson
	Address:	 	24995 Miller Cutoff Road
		 	Los Gatos, CA 95033
	Facsimile:	 	 

 Signature Page to Tender and Support Agreement 

 
			
	STOCKHOLDER
	
	 /s/ Thomas A. Armer

	 Name: 
	 	 Thomas A. Armer

	 Address:
	 	 1225 Estate Drive

		 	 Los Altos, CA 94024

	 Facsimile:
	 	 

 Signature Page to Tender and Support Agreement 

 
			
	STOCKHOLDER
	
	/s/ Christopher Y. Chai
	Name: 	 	Christopher Y. Chai
	Address:	 	1400 Mills Ave.
		 	Burlingame, CA 94010
	Facsimile:	 	 

 Signature Page to Tender and Support Agreement 

 
			
	STOCKHOLDER
	
	/s/ Charlene A. Friedman
	Name: 	 	Charlene A. Friedman
	Address:	 	143 Seminary Drive
		 	Menlo Park, CA 94025
	Facsimile:	 	 

 Signature Page to Tender and Support Agreement 

 
			
	STOCKHOLDER
	
	/s/ Anastasios E. Gianakakos
	Name: 	 	Anastasios E. Gianakakos
	Address:	 	560 Lemon Street
		 	Menlo Park, CA 94025
	Facsimile:	 	(650) 899-1600

 Signature Page to Tender and Support Agreement 

 
			
	STOCKHOLDER
	
	/s/ Donald J. Kellerman
	Name: 	 	Donald J. Kellerman
	Address:	 	1030 Glen Brook Avenue
		 	San Jose, CA 95125
	Facsimile:	 	 

 Signature Page to Tender and Support Agreement 

 
			
	STOCKHOLDER
	
	/s/ Scott Borland
	Name: 	 	Scott Borland
	Address:	 	16161 Escobar Drive
		 	Los Gatos, CA 95032
	Facsimile:	 	 

 Signature Page to Tender and Support Agreement 

 
			
	STOCKHOLDER
	
	/s/ Matthew V. McPherron
	Name: 	 	Matthew V. McPherron
	Address:	 	200 Clarendon Street
		 	Boston, MA 02116
	Facsimile:	 	 

 Signature Page to Tender and Support Agreement 

 
			
	STOCKHOLDER
	
	/s/ H. Ward Wolff
	Name:	 	H. Ward Wolff
	Address:	 	200 N. Almenar Drive
		 	Greenbrae, CA 94904
	Facsimile:	 	(415) 461-3889

 Signature Page to Tender and Support Agreement 

 
			
	STOCKHOLDER
	
	/s/ Scott R. Ward
	Name:	 	Scott R. Ward
	Address:	 	6410 Ballantine Ct
		 	Inver Grove Heights
		 	Minnesota, 55077
	Facsimile:	 	 

 Signature Page to Tender and Support Agreement 

 
			
	STOCKHOLDER
	
	/s/ Bernard J. Kelley
	Name:	 	Bernard J. Kelley
	Address:	 	1820 Rittenhouse Square #802
		 	Philadelphia, PA 19103
	Facsimile:	 	(215) 735-3664

 Signature Page to Tender and Support Agreement 

 
			
	STOCKHOLDER
	
	/s/ Gerri A. Henwood
	Name:	 	Gerri A. Henwood
	Address:	 	490 Lapp Rd
		 	Malvern, PA 19355
	Facsimile:	 	 

 Signature Page to Tender and Support Agreement 

 
			
	STOCKHOLDER
	
	/s/ W. James O’Shea
	Name:	 	W. James O’Shea
	Address:	 	6 Arlington Street
		 	Unit 6
		 	Boston, MA 02116
	Facsimile:	 	 

 Signature Page to Tender and Support Agreement 

 SCHEDULE A 
 Ownership of Shares(1) 
  

																													
	 Name
	  	Number of
Shares
Owned	 	  	Number of Shares
Subject to Vested
and Unexercised
Company
Stock
Options	 	  	Number of Shares
Subject to Unvested
and Unexercised
Company
Stock
Options	 	  	Number of
Company
RSUs	 	  	Number of
Shares of
Restricted
Stock	 	  	Number of
Subject
Shares	 	  	Shares that
May be Sold
Pursuant to
a 10b5-1
Plan	 
	 Brookside Capital Partners Fund, L.P.
	  	 	2,999,526	  	  	 	0	  	  	 	0	  	  	 	0	  	  	 	0	  	  	 	2,999,526	  	  	 	0	  
	 Timothy S. Nelson
	  	 	33,017	  	  	 	1,265,595	  	  	 	247,397	  	  	 	37,500	  	  	 	0	  	  	 	1,336,112	  	  	 	150,000	(2) 
	 Thomas A. Armer
	  	 	239,556	  	  	 	276,065	  	  	 	61,928	  	  	 	17,750	  	  	 	0	  	  	 	533,371	  	  	 	39,620	(2) 
		  				  				  				  				  				  				  	 	20,000	(3) 
	 Christopher Y. Chai
	  	 	10,979	  	  	 	268,435	  	  	 	63,282	  	  	 	17,750	  	  	 	0	  	  	 	297,164	  	  	 	0	  
	 Charlene A. Friedman
	  	 	1,307	  	  	 	207,267	  	  	 	63,282	  	  	 	17,750	  	  	 	0	  	  	 	226,324	  	  	 	0	  
	 Anastasios E. Gianakakos
	  	 	14,330	  	  	 	183,905	  	  	 	61,095	  	  	 	17,750	  	  	 	0	  	  	 	215,985	  	  	 	30,000	(2) 
	 Donald J. Kellerman, Pharm.D.
	  	 	1,986	  	  	 	143,501	  	  	 	62,449	  	  	 	17,750	  	  	 	0	  	  	 	163,237	  	  	 
	16,000
	(2) 

		  				  				  				  				  				  				  	 	1,429	(3) 
	 Scott Borland (4)
	  	 	9,475	  	  	 	120,620	  	  	 	67,527	  	  	 	21,075	  	  	 	0	  	  	 	151,170	  	  	 	0	  
	 Matthew V. McPherron (5)
	  	 	2,999,526	  	  	 	36,666	  	  	 	3,334	  	  	 	0	  	  	 	0	  	  	 	3,036,192	  	  	 	0	  
	 H. Ward Wolff
	  	 	0	  	  	 	59,166	  	  	 	3,334	  	  	 	0	  	  	 	0	  	  	 	59,166	  	  	 	0	  
	 Scott R. Ward
	  	 	2,000	  	  	 	59,166	  	  	 	3,334	  	  	 	0	  	  	 	0	  	  	 	61,166	  	  	 	0	  
	 Bernard J. Kelley
	  	 	0	  	  	 	53,615	  	  	 	3,334	  	  	 	0	  	  	 	0	  	  	 	53,615	  	  	 	0	  
	 Gerri A. Henwood
	  	 	0	  	  	 	29,166	  	  	 	3,334	  	  	 	0	  	  	 	0	  	  	 	29,166	  	  	 	0	  
	 W. James O’Shea
	  	 	0	  	  	 	5,000	  	  	 	15,000	  	  	 	0	  	  	 	0	  	  	 	5,000	  	  	 	0	  

	(1)	Vesting calculated as of January 17, 2013. 

	(2)	Represents the maximum number of Shares issuable upon exercise of stock options outstanding as of the date hereof that can be sold, solely pursuant to a 10b5-1 Plan
that is in existence as of the date hereof. 

	(3)	Represents the maximum number of Shares that are outstanding as of the date hereof that can be sold, solely pursuant to a 10b5-1 Plan that is in existence as of the
date hereof. 

	(4)	Common Stock held by Mr. Borland includes 1,586 shares of common stock held by his spouse, an employee of the Company, 16,720 and 1,050 shares of Common Stock
issuable upon exercise of options and vesting of restricted stock units, respectively, held by his spouse. 

	(5)	Includes shares held by Brookside Capital Partners Fund, L.P. Mr. McPherron is a managing director of Brookside Capital, LLC, an affiliate of Brookside Capital
Partners Fund, L.P., and disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.Letter Agreement

 Exhibit 10.1 
 January 18, 2013 
 Mr. Armand Correia 

122 Grand Palm Way 
 Palm Beach Gardens, FL 33418

 Dear Armand: 
 This release
agreement (“Agreement”) will confirm the terms of your retirement from employment with Ascena Retail Group, Inc. (the “Company”) on mutually agreeable terms as set forth below. You and the Company (collectively, the
“Parties”) agree that this Agreement represents the full and complete agreement concerning your separation from employment with the Company. 
 1. Last Day of Employment: You advised the Company on March 8, 2012, and the Company has agreed, that you will separate from service with the Company no later than March 2, 2013
(the date that you actually separate from service will be referred to in this Agreement as your “Termination Date”). It is mutually understood that this separation from service constitutes a separation from service as that term is defined
in Treasury Regulation Section 1.409A-1(n). Provided that you sign and return this Agreement without revoking it as set forth in paragraph 29 of this Agreement, you and the Company have agreed that, through March 2, 2013 (the
“Transition Period”), you will continue to handle your normal duties and will assist in the transition of your responsibilities and institutional knowledge to your successor. You will be paid your salary through your Termination Date. The
Company may require you to perform your duties remotely and not report to the office during any portion of the Transition Period, and at that time you will be required to execute this Agreement to obtain the benefits included herein. Regardless of
where your work is performed during the Transition Period, you understand that your duties will require you to work, at a minimum, thirty (30) hours per week. Except as otherwise provided in this Agreement or under applicable law, you will,
during the Transition Period, be covered by all Company benefit plans and supplementary or variable compensation plans (collectively, the “Company Plans”) in which you participated prior to March 8, 2012, in accordance with the terms
of such plans and applicable law, including without limitation medical/hospitalization and dental insurance benefits, executive life insurance, short-term disability and long-term disability insurance coverage, the 401(k) plan, the Long Term
Incentive Plan, the Management Incentive Plan (also known as the Cash Incentive Bonus Plan), the Stock Incentive Plan, and success Stock Awards for work on mergers and acquisitions, and you will be eligible for merit increases. Notwithstanding the
foregoing general continuation of your participation in the Company Plans, if, prior to March 2, 2013, you have a “separation from service,” as that phrase is defined for certain purposes under applicable IRS regulations, your
participation in some of the Company Plans may terminate by reason of applicable provisions of the Internal Revenue Code of 1986, as amended (the “Code”) or pursuant to express provisions of the relevant Company Plan. You will, however,
continue to be paid salary (or taxable compensation equal to your salary), and to be covered under those Company Plans in which such continued participation is permitted, regardless of whether you are in the office and/or whether your successor has
been hired. 

 2. Consideration: Provided that you sign and return the Supplemental Release attached to this
Agreement without revoking it as set forth in the Supplemental Release, the Company will, following your Termination Date: 
  

	 	(a)	Pay you the equivalent of fifty-two (52) weeks of pay at your rate of salary as of March 2, 2013, which will be paid out as severance pay, less
applicable withholding, in installments on the same bi-weekly pay schedule as the Company payroll. All taxable payments and benefits provided under this Agreement are intended to comply with the separation pay exception (as set forth in Treasury
Regulation Section 1.409A-1(b)(9)(iii)) of Section 409A of the Code; 

  

	 	(b)	Provided that you timely elect and enroll in COBRA, the Company will pay 100% of COBRA benefit premiums for a fifty-two (52) week period, unless you become
eligible and elect to participate in Medicare at an earlier time, in which event and at which time the Company will cover the cost of the Company’s medical benefits as supplemental coverage for Medicare, and will continue to cover the COBRA
cost for your spouse (for the remainder of the fifty-two (52) week period), should she elect to continue the Company’s medical benefits through COBRA after you elect to participate in Medicare. You will receive, under separate cover,
information and enrollment forms regarding continuing insurance coverage pursuant to COBRA. Notwithstanding the foregoing, in the event the Company determines that this arrangement is a violation of any federal healthcare reform laws or regulations,
or is a violation of any other applicable law or Company Plan, the provisions of this Section 2(b) shall, to the extent necessary to avoid any such violation of law or Company Plan, be a nullity and, provided that it does not constitute a
violation of any applicable law or Company Plan, the Company will pay you a lump sum that is equal, on a net basis after payment of all federal, state and local taxes imposed on such lump sum payment, to the cost of COBRA continuation coverage
premiums you would be required to pay to continue such coverage through March 2, 2014; 

  

	 	(c)	Pay you, on the first pay period after March 2, 2014, a lump sum that is equal, on a net basis after payment of all federal, state and local taxes imposed on such
lump sum payment, to the cost of 100% of COBRA continuation coverage premiums you would be required to pay to continue such coverage between March 3, 2014 through September 30, 2014; 

 

	 	(d)	Pay you an additional lump sum payment of ten thousand dollars ($10,000.00), less applicable withholding, that is intended for you to use to pay for the services of a
personal financial planner; 

  
 - 2 -

	 	(e)	Pay you a lump sum, less applicable withholding, which is equivalent to the amount that you would have been eligible to receive under the Management Incentive Plan
(also known as the Cash Incentive Bonus Plan) for Spring 2013 had you been employed by the Company at or after the time that payments to active employees are made in or about September 2013. The Parties agree that this payment will be made no
earlier than the time that payments to active employees are made under the Plan; provided further, however, that this payment will, in all events, be made no later than December 31, 2013; 

 

	 	(f)	Pay you a lump sum, less applicable withholding, which is the cash equivalent of your 2013 Long Term Incentive Program Award, if any, pursuant to the Company’s
2013 Long Term Incentive Program established by the Company under the terms of the Ascena Retail Group, Inc. 2010 Stock Incentive Plan, which payment shall be made on the basis of the Company’s actual performance through the end of fiscal 2013,
and which shall be paid at the same time and in the same manner as payments are made to other participants in the 2013 LTIP (which shall, in all events be paid no later than December 31, 2013); provided, however, that no requirement that you
remain actively employed by the Company after your Termination Date shall apply); and 

  

	 	(g)	Provide you with a Dress Barn associate discount for life. 

 3. Withholding on Payments: Taxes, applicable withholding and authorized or required deductions will be deducted from all payments to you. 

4. Employee Benefits: Except as expressly provided herein, in the Company Plans, in the Executive Retirement Plan, in the Executive
Deferred Compensation Plan, and/or as otherwise required by law, your employee benefits and participation in the Company Plans, including but not limited to medical/hospitalization and dental insurance benefits, executive life insurance, short-term
disability and long-term disability insurance coverage, the 401(k) plan, the Long Term Incentive Plan, the Management Incentive Plan (also known as the Cash Incentive Bonus Plan) and/or any other bonus payment plans, the Stock Incentive Plan, and
success Stock Awards for work on mergers and acquisitions, will terminate effective March 2, 2013, unless such coverage has terminated at an earlier date pursuant to limitations on continued coverage under applicable laws, regulations or the
terms of governing plan documents or insurance contracts. 
 5. COBRA: Following your Termination Date, you may elect to
continue medical/hospitalization and dental insurance coverage, as applicable, at your own expense, except as otherwise provided in paragraph 2(b) and 2(c), pursuant to a federal law known as COBRA. You will receive, under separate cover,
information regarding continuing medical/hospitalization and dental insurance coverage pursuant to COBRA. 
 6. Stock Options: Any
outstanding stock options granted to you may vest and will be exercisable as provided under the terms of the Company’s Stock Incentive Plan and the terms of the specific grants made to you as set forth on the applicable stock option
certificates. 

  
 - 3 -

 7. Life Insurance: You shall have such rights with regard to any “Split Dollar
Policy” (as that term is defined in the Company’s Executive Deferred Compensation Plan) in which you are the named insured as are provided for pursuant to the terms of such plan. 
 8. Accrued Vacation: You will be paid for all accrued but unused vacation. You understand that you are entitled to this payment regardless of whether you sign this Agreement. 

9. Unemployment Insurance: While the Company will not oppose a claim by you for unemployment insurance benefits, you must understand that
the State Department of Labor (“DOL”), not the Company, determines whether you are eligible to receive benefits and that you cannot raise any claim against the Company because of information that is provided to the DOL. 

10. Reimbursement of Business Expenses: You agree to submit, within thirty (30) days following your Termination Date, appropriate
documentation of all authorized business expenses incurred in connection with your performance of duties for the Company, and the Company will reimburse you in accordance with Company policy. You should submit such documentation to John Pershing at
the address set forth in paragraph 29 below. 
 11. References: You should direct all reference inquiries to John Pershing,
Executive Vice President, Human Resources. 
 12. Transition: Until your Termination Date, you agree to continue to perform your
duties in a professional manner and to cooperate in the orderly and smooth transition of your job responsibilities. After your Termination Date, you agree that you will be available, upon reasonable notice, to respond to questions and provide
assistance to the Company regarding any unfinished business, including but not limited to cooperating with the Company with respect to any litigation that may arise relating to matters on which you worked during your employment. 

13. No Other Payments: You understand and agree that absent this Agreement, you would not otherwise be entitled to the consideration
specified in this Agreement. Further, by signing this Agreement, you agree that you are not entitled to any payments and/or benefits that are not specifically listed in this Agreement, including but not limited to benefits under The Dress Barn, Inc.
Executive Severance Plan and/or the April 16, 2010 letter between you and The Dress Barn, Inc. relating thereto, the Management Incentive Plan (also known as the Cash Incentive Bonus Plan) and/or any other bonus payment plans, the Stock
Incentive Plan, and the Long Term Incentive Plan. You will, however, be entitled to such benefits as are provided for under the Company’s tax qualified retirement plans and non-qualified plans in which you have a vested right, such as the
Company’s 401(k) plan and Executive Retirement Plan. You further agree and acknowledge that upon the Company’s providing the payments and other benefits set forth in this Agreement, the Company has paid you in full any and all monies owed
to you in connection with your 

  
 - 4 -

 employment with the Company and separation from employment, including but not limited to payment for all
services performed on behalf of the Company and any amounts that may otherwise have been payable to you in the nature of severance, except as otherwise specifically stated in this Agreement. 
 14. General Release of All Claims: In exchange for the Company’s payments and other consideration as set forth in this Agreement, you release Ascena Retail Group, Inc., and each of its
subsidiaries, affiliates, predecessors, successors, assigns, officers, directors, trustees, employees and agents (hereinafter collectively referred to as “Releasees”) from any and all claims that may legally be waived by private agreement,
known or unknown, including but not limited to those related to your employment, your separation from employment or otherwise, from the beginning of time through the date that you sign this Agreement, except as otherwise specifically stated in this
Agreement. 
 You understand and agree that you are releasing Releasees from any and all claims that may legally be waived by private agreement,
including but not limited to claims for breach of contract, personal injury, wages, benefits, defamation, wrongful discharge, and any and all claims based on any oral or written agreements or promises, whether arising under statute (including, but
not limited to, claims arising under the Employee Retirement Income Security Act of 1974, the Equal Pay Act, the Family and Medical Leave Act, the New York State Labor Law, the New York State Whistleblower Statute, and any other federal, state,
local or foreign laws or regulations), contract (express or implied), constitutional provision, common law, tort, public policy or otherwise, from the beginning of time through the date that you sign this Agreement. 

You understand and agree that you are also releasing Releasees from any and all claims that may legally be waived by private agreement, including but not
limited to claims for retaliation, and claims for discrimination or harassment in employment on the basis of race, color, creed, religion, age, national origin, alienage or citizenship, gender, sexual orientation, disability, genetic information,
marital status, veteran’s status and any other protected grounds, including, but not limited to, any and all rights and claims you may have arising under Title VII of the Civil Rights Act of 1964, the Americans with Disabilities Act, the Age
Discrimination in Employment Act of 1967, the New York State Human Rights Law, and any other federal, state, local or foreign laws or regulations, from the beginning of time through the date that you sign this Agreement. 

15. No Claims Filed: Except as otherwise stated below, you agree and covenant not to file any suit, complaint, claim, grievance or demand
for arbitration against any of Releasees, either individually or as a member of a class in any class or collective action, in any court or other forum with regard to any claim, demand, liability or obligation arising out of your employment with the
Company and/or separation from employment. You further represent that no claims, complaints or other proceedings are pending in any court or other forum relating directly or indirectly to your employment with the Company and/or separation from
employment. You understand that nothing in this Agreement shall be construed to prohibit you from filing a charge with, or participating in any investigation or proceeding conducted by, the National Labor Relations Board, Equal Employment
Opportunity Commission, and/or any federal, state, local or foreign agency charged with the enforcement of any 

  
 - 5 -

 
employment laws, although by signing this Agreement, you understand that you are waiving your right to receive individual relief based on claims asserted in such a charge or complaint, except
where such a waiver is prohibited. You understand that your release of claims as contained in the Agreement does not extend to any rights you may have under the Fair Labor Standards Act, and/or or under any laws governing the filing of claims for
unemployment and/or workers’ compensation benefits. You further understand that nothing herein shall be construed to prohibit you from challenging: (a) the Company’s failure to comply with its promises to make payments and provide
benefits under this Agreement; (b) your right to any vested benefits to which you are entitled; and/or (c) the knowing and voluntary nature of your release of claims under the Age Discrimination in Employment Act of 1967. 

16. Confidential Information: 
  

	 	(a)	You agree that you shall not disclose any confidential or proprietary information you learned or acquired while employed by the Company, including, but not limited to,
personnel and compensation information; financial information and data; technical data and information; programmatic and operational information; customer identities and information; marketing plans, data and information; business information;
strategy and program-specific research; information related to the Company’s computer and/or communications systems; and/or information the nature of which would commonly be reasonably understood to be confidential (hereinafter referred to
collectively as “Confidential Information”), except as required by law. You further promise that you shall not directly or indirectly use, disclose, reproduce, sell, retain, remove from the premises, make available to any other person or
entity, or use for your own or for any other person or entity’s benefit, any portion of the Confidential Information. You also promise that you shall not use any such Confidential Information to damage the Company, its interests or its clients,
or any other person or entity with whom the Company does business; and 

  

	 	(b)	By signing below, you represent that you shall: (i) on or before your Termination Date return to the Company any and all Confidential Information and all other
materials, documents or property belonging to the Company or any of its affiliated entities, and any and all copies thereof, whether in hard copy or electronic form, which were in your possession or under your control, including without limitation
files, documents, lists, records, manuals, reports, software and hardware, laptops, printers, computers, cell phone, blackberry or other PDA, keys, equipment, identification cards, access card, credit cards, mailing lists, rolodexes, personnel
information, electronic information and files, computer print-outs, and computer disks and tapes, (ii) not retain any copies of any Confidential Information and/or any other materials, documents or property belonging to Releasees, and
(iii) permanently delete all Confidential Information from your home and/or personal computer drives and from any other personal electronic, digital or magnetic storage devices. 

  
 - 6 -

 17. [INTENTIONALLY OMITTED]  
 18. No Negative Statements: You agree not to make, directly or indirectly, to any person or entity, including but not limited to the Company’s past and/or present employees, Board of
Directors, and/or the press, any negative or disparaging oral or written statements about, or do anything which damages, any of the Releasees, or its or their services, good will, reputation or financial status, or which damages it or them in any of
its or their business relationships. Nothing in this paragraph shall preclude you from testifying honestly if required by law to testify in any legal proceeding or governmental investigation. 
 19. Restrictive Covenants: For a period of twenty-four (24) months after your Termination, you agree that you shall not, directly or indirectly, individually or on behalf of any other
person, firm, corporation or other entity, recruit or hire, or attempt to recruit or hire, any associate of any of the Releasees, or otherwise solicit, aid, induce or attempt to influence any associate to leave the employment of any of the
Releasees. 
 20. Breach of Agreement: You acknowledge that the Company would be irreparably injured by a violation by you of
paragraphs 16, 18 and/or 19, and you agree that in the event of any such breach or threatened breach, the Company shall, in addition to any other remedies available to it, be entitled to: (i) a temporary restraining order and/or preliminary
and/or permanent injunction, or other equivalent relief, restraining you from any actual or threatened breach of paragraphs 16, 18 and/or 19, and (ii) discontinue making any further payments under this Agreement, and recover the amounts paid to
you pursuant to paragraph 2(a), as well as damages, attorneys’ fees and other costs incurred by the Company in obtaining such relief. 

21. Nonadmission of Wrongdoing: By entering into this Agreement, neither you nor any of the Releasees admit any wrongdoing or violation of
law. 
 22. Changes to the Agreement: This Agreement may not be changed unless the changes are in writing and signed by you and
either the Company’s President and CEO, or the Executive Vice President of Human Resources. 
 23. Applicable Law; Consent to
Jurisdiction: This Agreement shall be interpreted, enforced and governed under the laws of the State of New York. You and the Company consent to the jurisdiction of the courts of the State of New York and/or the federal district courts of
the Southern District of New York, for the purpose of resolving all issues of law, equity, and/or fact arising out of or in connection with this Agreement. Any action involving claims of a breach of this Agreement shall be brought in such courts
exclusively. Each party consents to personal jurisdiction over such party in the state and/or federal courts of New York and hereby waives any defense of lack of personal jurisdiction. Venue, for the purpose of all such suits, shall be in New York
County, State of New York, exclusively. 
 24. Supplemental Release: On or after, but not before, your Termination Date, you must
sign the attached Supplemental Release and return it to John Pershing, Executive Vice President of Human Resources, or his designee, Ascena Retail Group, Inc., 30 Dunnigan Drive, Suffern, NY 10901. 

  
 - 7 -

 25. Severability: You agree that in the event that any provision of this Agreement is
judicially declared to be invalid or unenforceable, only such provision or provisions shall be invalid or unenforceable without invalidating or rendering unenforceable the remaining provisions hereof, which shall remain in full force and effect to
the fullest extent permitted by law. 
 26. Entire Agreement: This Agreement contains the entire agreement between you and
the Company and supersedes and replaces any prior agreements or understandings between you and the Company, whether written or oral, including but not limited to The Dress Barn, Inc. Executive Severance Plan and the April 16, 2010 letter
between you and The Dress Barn, Inc. relating thereto, which are hereby superseded, null and void. 
 27. Waiver: By
signing this Agreement, you acknowledge that: 
  

	 	(a)	You have carefully read, and understand, this Agreement; 

  

	 	(b)	You have been given at least twenty-one (21) days to consider your rights and obligations under this Agreement and to consult with an attorney and/or any other
advisors of your choice before signing this Agreement, and agree that changes to this Agreement, whether material or immaterial, do not restart the running of the twenty-one (21) day period; 

 

	 	(c)	By this paragraph of the Agreement, the Company advised you to consult with an attorney and/or any other advisors of your choice before signing this Agreement;

  

	 	(d)	You understand that this Agreement is legally binding and by signing it you give up certain rights; 

 

	 	(e)	You have voluntarily chosen to enter into this Agreement and have not been forced or pressured in any way to sign it; 

 

	 	(f)	You have not relied upon any representation, statement or omission made by any of the Company’s agents, attorneys or representatives with regard to the subject
matter, basis or effect of this Agreement or otherwise, other than those expressly stated in this Agreement; 

  

	 	(g)	You knowingly and voluntarily release Releasees from any and all claims you may have, known or unknown, in exchange for the payments and other benefits you have
obtained by signing, and acknowledge that these payments and other benefits are in addition to any benefit you would have otherwise received if you did not sign this Agreement; and 

 

	 	(h)	This Agreement does not waive any rights or claims that may arise after this Agreement is signed. 

28. Return of Signed Agreement: You should sign and return this signed Agreement to John Pershing, Executive Vice President of Human
Resources, or his designee, Ascena Retail Group, Inc., 30 Dunnigan Drive, Suffern, NY 10901, no later than twenty-one (21) days after the date that you receive this Agreement. If you do not return the signed Agreement to Mr. Pershing or
his designee by that date, this Agreement shall be deemed revoked, null, void and of no effect, and you shall have no entitlement to pay, benefits or any consideration as set forth in this Agreement. 

  
 - 8 -

 29. Effective Date and Revocation Period: You have seven (7) days
from the date you sign this Agreement to change your mind and revoke this Agreement. If you do not advise the Company in writing within seven (7) days that you have revoked this Agreement, this Agreement shall be effective, enforceable and
binding on all Parties on the eighth (8th) day after you
sign it. If you change your mind and revoke this Agreement, you must send written notice of your decision to John Pershing, Executive Vice President of Human Resources, or his designee, Ascena Retail Group, Inc., 30 Dunnigan Drive, Suffern, NY
10901, so that he receives your revocation no later than the eighth (8th) day after you originally signed the Agreement. You should understand that the Company will not be required to make the payments or provide the consideration set forth in this Agreement unless this
Agreement becomes effective. 
  

	
	Sincerely,
	
	 /s/ John Pershing

	John Pershing
	Executive Vice President,
	Human Resources

 Read, Accepted and Agreed: 
  

					
	 /s/ Armand Correia
	 		  	 1/22/13

	 Armand Correia
	 		  	Date

  

					
	STATE OF NEW YORK)	  		  	

					
		 	: ss.:	  	

					
	COUNTY OF ROCKLAND)	  		  	

 On the 22nd day of January, 2013 before me personally came Armand Correia, to me known and known to me to be the individual
described in, and who executed, the foregoing Agreement, and duly acknowledged to me that he executed the same. 
  

			
	/s/ Gene Wexler	 	 
	Notary Public         	 	

 GENE WEXLER 
 Notary Public, State of New York 
 No. O2WE6036419 

Qualified in Westchester County 
 Commission Expires 1/24/14 

  
 - 9 -

 SUPPLEMENTAL RELEASE 

In exchange for the payments and benefits described in the release agreement dated January 18, 2013 (the “Agreement”), I release
Ascena Retail Group, Inc., and each of its subsidiaries, affiliates, predecessors, successors, assigns, officers, directors, trustees, employees and agents (hereinafter collectively referred to as “Releasees”) from any and all claims that
may legally be waived by private agreement, known or unknown, including but not limited to those related to my employment, my separation from employment or otherwise, from the beginning of time through the date that I sign this Supplemental Release,
except as otherwise specifically stated in the Agreement or this Supplemental Release. 
 I understand and agree that I am releasing Releasees
from any and all claims that may legally be waived by private agreement, including but not limited to claims for breach of contract, personal injury, wages, benefits, defamation, wrongful discharge, and any and all claims based on any oral or
written agreements or promises, whether arising under statute (including, but not limited to, claims arising under the Employee Retirement Income Security Act of 1974, the Equal Pay Act, the Family and Medical Leave Act, the New York State Labor
Law, the New York State Whistleblower Statute, and any other federal, state, local or foreign laws or regulations), contract (express or implied), constitutional provision, common law, tort, public policy or otherwise, from the beginning of time
through the date that I sign this Supplemental Release. 
 I understand and agree that I am also releasing Releasees from any and all claims
that may legally be waived by private agreement, including but not limited to claims for retaliation, and claims for discrimination or harassment in employment on the basis of race, color, creed, religion, age, national origin, alienage or
citizenship, gender, sexual orientation, disability, genetic information, marital status, veteran’s status and any other protected grounds, including, but not limited to, any and all rights and claims I may have arising under Title VII of the
Civil Rights Act of 1964, the Americans with Disabilities Act, the Age Discrimination in Employment Act of 1967, the New York State Human Rights Law, and any other federal, state, local or foreign laws or regulations, from the beginning of time
through the date that I sign this Supplemental Release. 
 Except as otherwise stated below, I agree and covenant not to file any suit,
complaint, claim, grievance or demand for arbitration against any of Releasees, either individually or as a member of a class in any class or collective action, in any court or other forum with regard to any claim, demand, liability or obligation
arising out of my employment with the Company and/or separation from employment. I further represent that no claims, complaints or other proceedings are pending in any court or other forum relating directly or indirectly to my employment with the
Company and/or separation from employment. I understand that nothing in this Agreement shall be construed to prohibit me from filing a charge with, or participating in any investigation or proceeding conducted by, the National Labor Relations Board,
Equal Employment Opportunity Commission, and/or any federal, state, local or foreign agency charged with the enforcement of any employment laws, although by signing this Supplemental Release, I understand that I am waiving my right to receive
individual relief based on claims asserted in such a charge or complaint, except where such 

  
 - 10 -

 
a waiver is prohibited. I understand that my release of claims as contained in the Agreement does not extend to any rights I may have under the Fair Labor Standards Act, or under any laws
governing the filing of claims for unemployment and/or workers’ compensation benefits. I further understand that nothing herein shall be construed to prohibit me from challenging: (a) the Company’s failure to comply with its promises
to make payments and provide benefits under the Agreement; (b) my right to any vested benefits to which I am entitled; and/or (c) the knowing and voluntary nature of my release of claims under the Age Discrimination in Employment Act of
1967. 
 I understand that I have seven (7) days from the date I sign this Supplemental Release to change my mind and
revoke this Supplemental Release. I understand that if I do not advise the Company in writing within seven (7) days that I have revoked this Supplemental Release, this Supplemental Release shall be effective, enforceable and binding on all
Parties on the eighth (8th) day after I sign it. I further
understand that if I change my mind and revoke this Supplemental Release, I must send written notice of my decision to John Pershing, Executive Vice President of Human Resources, or his designee, Ascena Retail Group, Inc., 30 Dunniganth Drive,
Suffern, NY 10901, so that he receives my revocation no later than the eighth (8th) day after I originally signed this Supplemental Release. I understand that the Company will not be required to make the payments or provide the consideration set forth in the Agreement unless the
Agreement, including this Supplemental Release, becomes effective. 
  

					
	  
	 		  	  

	 Armand Correia
	 		  	 Date

  

					
	STATE OF                     )	  		  	

					
		 	: ss.:	  	

					
	COUNTY OF                   )	  		  	

 On the      day of
            , 201     before me personally came Armand Correia, to me known and known to me to be the individual described in, and who executed, the foregoing
Supplemental Release, and duly acknowledged to me that he executed the same. 
  

			
	  	 	 
	Notary Public         	 	

  
 - 11 -

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00211-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00211-of-00352.parquet"}]]